Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Cervera

Showing results (101-110 of 412) with videos related to

Pageof 42
Sort By:
The Journal of Rheumatology|June 7, 2006
Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis?Ronald A Asherson, Ricard Cervera, Daniel Shepshelovich, et al.
Lupus|August 22, 2020
16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid SyndromeRicard Cervera, Ignasi Rodríguez-Pintó, Kim Legault, et al.
Rheumatology (Oxford, England)|May 7, 2020
Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparisonMargarida Oliveira, Sergio Palacios-Fernandez, Ricard Cervera, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 28, 2019
Overrepresentation of Elderly Subjects in a Population-Based Study of Antiphospholipid Syndrome: Comment on the Article by Duarte-García et alJose A Gómez-Puerta, Ricard Cervera, Graciela S Alarcón
Autoimmunity Reviews|July 9, 2008
Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical valueJosé A Gómez-Puerta, Rufus W Burlingame, Ricard Cervera
Seminars in Thrombosis and Hemostasis|August 23, 2008
Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factorsGerard Espinosa, Silvia Bucciarelli, Ronald A Asherson, et al.
The Journal of Rheumatology|September 3, 2014
Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosusLaura Magnano, Hector Enríquez, Jordi Esteve, et al.
European Journal of Internal Medicine|February 5, 2020
Treat-to-target in systemic lupus erythematosus: Where are we?Roberto Ríos-Garcés, Gerard Espinosa, Ronald van Vollenhoven, et al.
Clinical Therapeutics|August 14, 2019
Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysisJorge Sanchez-Redondo, Gerard Espinosa, David Varillas Delgado, et al.
Autoimmunity Reviews|November 1, 2011
Does seronegative antiphospholipid syndrome really exist?Ricard Cervera, Fabrizio Conti, Andrea Doria, et al.
Pageof 42

Showing results (101-110 of 412) with videos related to

Sort By:
Pageof 42
The Journal of Rheumatology|June 7, 2006
Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis?Ronald A Asherson, Ricard Cervera, Daniel Shepshelovich, et al.
Lupus|August 22, 2020
16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid SyndromeRicard Cervera, Ignasi Rodríguez-Pintó, Kim Legault, et al.
Rheumatology (Oxford, England)|May 7, 2020
Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparisonMargarida Oliveira, Sergio Palacios-Fernandez, Ricard Cervera, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 28, 2019
Overrepresentation of Elderly Subjects in a Population-Based Study of Antiphospholipid Syndrome: Comment on the Article by Duarte-García et alJose A Gómez-Puerta, Ricard Cervera, Graciela S Alarcón
Autoimmunity Reviews|July 9, 2008
Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical valueJosé A Gómez-Puerta, Rufus W Burlingame, Ricard Cervera
Seminars in Thrombosis and Hemostasis|August 23, 2008
Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factorsGerard Espinosa, Silvia Bucciarelli, Ronald A Asherson, et al.
The Journal of Rheumatology|September 3, 2014
Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosusLaura Magnano, Hector Enríquez, Jordi Esteve, et al.
European Journal of Internal Medicine|February 5, 2020
Treat-to-target in systemic lupus erythematosus: Where are we?Roberto Ríos-Garcés, Gerard Espinosa, Ronald van Vollenhoven, et al.
Clinical Therapeutics|August 14, 2019
Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysisJorge Sanchez-Redondo, Gerard Espinosa, David Varillas Delgado, et al.
Autoimmunity Reviews|November 1, 2011
Does seronegative antiphospholipid syndrome really exist?Ricard Cervera, Fabrizio Conti, Andrea Doria, et al.
Pageof 42